PathGroup’s new Vaginal Health Portfolio utilizes the most advanced PCR technology, providing accurate and actionable answers in less time for the most common infections of the genital tract. And with a dedicated panel for Bacterial Vaginosis, you’ll gain valuable insights into your patient’s vaginal ecosystem for more targeted and effective management.

PathGroup’s Vaginal Health Portfolio is comprised of tailored, infection-specific panels providing clinically relevant and actionable results for:

• Bacterial Vaginosis+
• Candida
• Leukorrhea
• Vaginitis
• Aerobic Vaginitis
• STI/STD
• Genital Ulcer

Early & Accurate Detection

• Industry leading turnaround times
• 31 organisms providing superior sensitivity and specificity
• Clinically relevant, infection-specific panels
• Single sample, convenient collection

In-Network Strategy

• All insurances accepted – preferred provider status with an extensive payer list
• Over 98% of claims are processed in-network annually
• Meaningful, cost-conscience test utilization

Innovative Technology, Actionable Results

• Tailored, clinically relevant panels focused on key infectious organisms
• Advanced PCR technology for quantitative results
• Straightforward reports with simple informatics and clinically actionable data
• HL7-compliant reports for ease of use and interpretation

 

To partner with PathGroup, call 800.366.5847 or email marketing@pathgroup.com for more information.